Lp-PLA2-IN-2 manufacturers
- Lp-PLA2-IN-2
-
- $2120.00
-
2026-05-11
- CAS:2071636-15-0
- Purity:
- Supply Ability: 10g
- Lp-PLA2-IN-2
-
- $2120.00
-
2025-08-22
- CAS:2071636-15-0
- Purity:
- Supply Ability: 10g
|
| | Lp-PLA2-IN-2 Basic information |
| Product Name: | Lp-PLA2-IN-2 | | Synonyms: | Lp-PLA2-IN-2;LpPLA2IN2,Lp-PLA-2-IN-2,Lp PLA2 IN 2;Benzonitrile, 2-fluoro-5-[2-[(4S)-2-oxo-4-(tetrahydro-4-methyl-1,1-dioxido-2H-thiopyran-4-yl)-1-pyrrolidinyl]ethoxy]- | | CAS: | 2071636-15-0 | | MF: | C19H23FN2O4S | | MW: | 394.46 | | EINECS: | | | Product Categories: | | | Mol File: | 2071636-15-0.mol |  |
| | Lp-PLA2-IN-2 Chemical Properties |
| Boiling point | 637.6±55.0 °C(Predicted) | | density | 1.34±0.1 g/cm3(Predicted) | | pka | -0.95±0.40(Predicted) |
| | Lp-PLA2-IN-2 Usage And Synthesis |
| Uses | Lp-PLA2-IN-2 is a potent and selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 0f 120 nM for recombinant human Lp-PLA2[1]. | | in vivo | Lp-PLA2-IN-2 (1 mg/kg; i.v.) treament in rats shows that the Cl, Vss and t1/2 values are 67 mL/min/kg, 1.2 L/kg, and 0.34 hours, respectively[1]. | Animal Model: | Male Han Wistar rats (250-300 g)[1] | | Dosage: | 1 mg/kg | | Administration: | i.v. (Pharmacokinetic Analysis) | | Result: | The Cl, Vss and t1/2 values were 67 mL/min/kg, 1.2 L/kg, and 0.34 hours, respectively. |
| | IC 50 | Lp-PLA2: 120 nM (IC50) | | References | [1] Woolford AJ, et al. Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2). J Med Chem. 2016 Dec 8;59(23):10738-10749. DOI:10.1021/acs.jmedchem.6b01427 |
| | Lp-PLA2-IN-2 Preparation Products And Raw materials |
|